Works matching IS 0008543X AND DT 2018 AND VI 124 AND IP 24


Results: 23
    2
    4
    5
    6
    7

    ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin-bound paclitaxel with or without CC-486 as second-line treatment for advanced nonsquamous non-small cell lung cancer (NSCLC).

    Published in:
    2018
    By:
    • Morgensztern, Daniel;
    • Cobo, Manuel;
    • Ponce Aix, Santiago;
    • Postmus, Pieter E.;
    • Lewanski, Conrad R.;
    • Bennouna, Jaafar;
    • Fischer, Jürgen R.;
    • Juan‐Vidal, Oscar;
    • Stewart, David J.;
    • Fasola, Gianpiero;
    • Ardizzoni, Andrea;
    • Bhore, Rafia;
    • Wolfsteiner, Marianne;
    • Talbot, Denis C.;
    • Jin Ong, Teng;
    • Govindan, Ramaswamy;
    • on behalf of the ABOUND.2L+ Investigators;
    • Juan-Vidal, Oscar;
    • On Behalf Of The Abound L Investigators
    Publication type:
    journal article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    21
    22
    23

    Issue Information.

    Published in:
    Cancer (0008543X), 2018, v. 124, n. 24, p. 4581, doi. 10.1002/cncr.31017
    Publication type:
    Article